NANOMEDICINE: will it offer possibilities to overcome multiple drug resistance in cancer? [PDF]
J Nanobiotechnology, 2016 Friberg S, Nyström AM.
europepmc +1 more source
Origin and proliferation of multiple-drug resistance in bacterial pathogens. [PDF]
Microbiol Mol Biol Rev, 2015 Chang HH +5 more
europepmc +1 more source
Chalcones Repressed the AURKA and MDR Proteins Involved in Metastasis and Multiple Drug Resistance in Breast Cancer Cell Lines. [PDF]
Molecules, 2018 Komoto TT +8 more
europepmc +1 more source
Effect of multiple drug resistance on total medical costs among patients with intra-abdominal infections in China. [PDF]
PLoS One, 2018 Zhen X +5 more
europepmc +1 more source
Development, Maintenance, and Reversal of Multiple Drug Resistance: At the Crossroads of TFPI1, ABC Transporters, and HIF1. [PDF]
Cancers (Basel), 2015 Arnason T, Harkness T.
europepmc +1 more source
Multiple-Drug Resistance in Burn Patients: A Retrospective Study on the Impact of Antibiotic Resistance on Survival and Length of Stay. [PDF]
J Burn Care Res, 2017 van Langeveld I +6 more
europepmc +1 more source
ANTIBACTERIAL ACTIVITY OF DRACONTOMELON DAO EXTRACTS ON METHICILLIN-RESISTANT S. AUREUS (MRSA) AND E. COLI MULTIPLE DRUG RESISTANCE (MDR). [PDF]
Afr J Infect Dis, 2018 Yuniati Y +4 more
europepmc +1 more source
Overcoming multiple drug resistance mechanisms in medulloblastoma. [PDF]
Acta Neuropathol Commun, 2014 Othman RT +8 more
europepmc +1 more source
Delivery of miR-375 and doxorubicin hydrochloride by lipid-coated hollow mesoporous silica nanoparticles to overcome multiple drug resistance in hepatocellular carcinoma. [PDF]
Int J Nanomedicine, 2017 Xue H +9 more
europepmc +1 more source
Erratum: Delivery Of miR-375 And Doxorubicin By Lipid-Coated Hollow Mesoporous Silica Nanoparticles To Overcome Multiple Drug Resistance In Hepatocellular Carcinoma [Corrigendum]. [PDF]
Int J Nanomedicine, 2019 europepmc +1 more source